Result of AGM
Updated : 11:07
IXICO plc
("IXICO" or the "Company")
Results of AGM
IXICO plc (AIM: IXI), the AI digital technologies company serving neuroscience, announces that all resolutions put forward to its Annual General Meeting held earlier today were duly passed and the votes cast were as follows:
Resolution | Description | Total Votes For | % Votes | Total Votes Against | Withheld |
1 | Reports and Accounts
| 30,185,052 | 99.95%
| 15,600 | 400 |
2 | Re-election of Directors |
|
|
|
|
Re-election of Mark Warne
| 30,185,152
| 99.95% | 15,900
| 0
| |
Re-election of John Bradshaw | 30,185,452 | 99.95% | 15,600 | 0 | |
3 | Re-appointment of Auditors
| 30,065,960 | 99.57% | 128,100 | 6,992 |
4 | Allotment of Securities
| 30,180,960 | 99.94% | 17,100 | 2,992 |
5 | Disapply Pre-Emption Provisions
| 30,180,010 | 99.94% | 18,050 | 2,992 |
6 | Amendment of rule 3.6.1 of the Company's 2014 EMI Share Option Plan
| 30,165,610 | 99.89% | 33,350 | 1,992 |
For further information please contact:
IXICO plc | +44 (0)20 3763 7498 | |||
Giulio Cerroni, Chief Executive Officer Grant Nash, Chief Financial Officer |
| |||
|
| |||
Cenkos Securities PLC (Nominated adviser and sole broker) | +44 (0)20 7397 8900 | |||
Giles Balleny / Max Gould (Corporate Finance) |
| |||
Michael F Johnson / Russell Kerr (Sales) |
| |||
|
| |||
Walbrook PR Ltd | +44 (0)20 7933 8780 | |||
Paul McManus / Lianne Cawthorne / | ||||
Alice Woodings |
| |||
|
|
|
|
|
About IXICO
IXICO is dedicated to delivering insights in neuroscience. Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience and our goal is to be a leading proponent of artificial intelligence in medical image analysis. We will achieve this by developing and deploying breakthrough data analytics, at scale, through our remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for our pharmaceutical clients.
More information is available on www.IXICO.com and follow us on Twitter @IxicOplc
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.